A Collaboration Leveraging Vanderbilt’s Innovative Life Science Research
And Deerfield’s Expertise In Accelerating State-Of-The-Art Drug Development
Investigator RFP Information Session
March 12th, 2019
2:00-3:30 1220 MRB III
Please join representatives of Vanderbilt CTTC, Ancora Innovation and Deerfield Management to learn more about the RFP that opens Mar 14th, 2019. Faculty will access the RFP submission portal through the Request for Proposal link above. Information Session slides are available to those who register on the Request for Proposal page.
On April 6, 2018, Vanderbilt University and Deerfield Management announced the launch of Ancora Innovation, a collaboration focused on the union of Vanderbilt’s innovative life science discovery efforts and Deerfield’s commitment to accelerating state-of-the-art drug development. Deerfield will fund Ancora Innovation with up to $65 million to pursue novel therapeutics and will provide additional capital to fund successful start-up companies that spin out of Ancora.
Ancora Innovation empowers Vanderbilt scientists with the capital and infrastructure to execute novel and potentially transformative research projects.